Cancel
Known information
- Earned an M.S. in Medical Biotechnologies and a Ph.D. in Molecular Medicine at the University of Milan
- Was a post-doctoral research scientist at Texas Tech University Health Sciences Center
- Is an expert in molecular immunology and immunotherapy research
- Has authored more than 100 publications including original research papers, abstracts, and book chapters
- His studies have focused on the interactions between tumor cells and immune cells, primarily the tumor microenvironment, neoangiogenesis, and cell signaling
- Is the inventor of nine different patent-pending technologies related to tumor biomarker identification, cancer vaccines, and adoptive cell therapies
About Kiromic BioPharma
Kiromic BioPharma, based in Houston, Texas, focuses on developing innovative cell therapies for cancer using its proprietary DIAMOND AI and ABBIE platforms to enhance target identification and improve manufacturing processes.
Report inaccurate information
